Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.

@article{Bender2007MemoryIW,
  title={Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.},
  author={Catherine M. Bender and Susan M. Sereika and Adam M. Brufsky and Christopher M Ryan and Victor G. Vogel and Priya Rastogi and Susan Murphy Cohen and Frances E Casillo and Sarah L. Berga},
  journal={Menopause},
  year={2007},
  volume={14 6},
  pages={995-8}
}
OBJECTIVE Hormones have been implicated as modulators of cognitive functioning. For instance, results of our previous work in women with breast cancer showed that cognitive impairment was more severe and involved more memory domains in those who received adjuvant tamoxifen therapy compared with women who received chemotherapy alone or no adjuvant therapy. Recently aromatase inhibitors such as anastrozole have been used in lieu of tamoxifen for the adjuvant treatment of postmenopausal women with… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 56 extracted citations

Similar Papers

Loading similar papers…